Company Overview

Surgery Partners, Inc. is a publicly traded healthcare services company that owns and operates a national network of outpatient surgical facilities and ancillary healthcare services. The company operates primarily within the ambulatory surgery, short-stay surgical hospital, and physician services segments of the U.S. healthcare industry. Its core business focuses on delivering lower-cost, high-quality surgical care in non-hospital settings, primarily serving patients requiring elective and minimally invasive procedures.

The company’s primary revenue drivers include surgical case volumes across its facilities, facility management services, and ancillary offerings such as anesthesia and diagnostic services. Surgery Partners serves physicians, commercial payors, and government programs, with a strategic emphasis on orthopedic, gastrointestinal, pain management, cardiovascular, and general surgery specialties. Founded in 2004 with backing from private equity investors, the company expanded through acquisitions and facility development, completing its initial public offering in 2015 and significantly increasing scale through the acquisition of AmSurg Corp. in 2023.

Business Operations

Surgery Partners generates revenue through the ownership and operation of Ambulatory Surgery Centers (ASCs), Short-Stay Surgical Hospitals, and related Ancillary Services. The company’s operating model emphasizes physician alignment through joint venture ownership structures, which are designed to drive case volume, operational efficiency, and clinical quality. Revenue is derived from patient service fees reimbursed by commercial insurers, Medicare, Medicaid, and other payors.

Operations are primarily domestic, with facilities distributed across multiple U.S. states. Key assets include surgical real estate, long-term payor contracts, clinical management systems, and employed or affiliated physician networks. Following the integration of AmSurg Corp., Surgery Partners significantly expanded its managed ASC portfolio and anesthesia services capabilities. The company does not report material international operations, and no major foreign joint ventures have been disclosed in public filings.

Strategic Position & Investments

Surgery Partners’ strategy centers on benefiting from the long-term shift of surgical procedures from inpatient hospital settings to lower-cost outpatient environments. Growth initiatives include expanding existing facilities, developing de novo ASCs, recruiting physician partners, and optimizing payor contracting. The acquisition of AmSurg Corp. represents a transformational investment, substantially increasing scale, geographic density, and bargaining power with commercial payors.

The company has also invested in operational technologies related to revenue cycle management, scheduling, and clinical efficiency, though it does not position itself as a healthcare technology developer. Strategic ownership and influence from private equity sponsor H.I.G. Capital has supported capital access, acquisition execution, and balance sheet management. Public disclosures indicate continued focus on deleveraging and integration execution rather than diversification into unrelated healthcare sectors.

Geographic Footprint

Surgery Partners operates exclusively within the United States, with corporate headquarters located in Brentwood, Tennessee. Its facilities span a broad national footprint, with particularly strong presence in the Southeast, Texas, the Midwest, and the Western United States. The acquisition of AmSurg Corp. increased density in urban and suburban markets and expanded relationships with health systems and physician groups nationwide.

The company does not report material exposure to international markets and does not generate significant revenue outside the U.S. All reported operations, investments, and regulatory oversight fall under U.S. federal and state healthcare frameworks.

Leadership & Governance

Surgery Partners is led by an executive team with extensive experience in healthcare services, outpatient surgery operations, and private equity–backed growth strategies. The leadership emphasizes physician partnership, disciplined capital allocation, and scalable operational execution, consistent with disclosures in SEC filings and investor communications.

Key executives include:

• Eric Evans – Chief Executive Officer
• David Doherty – Chief Financial Officer
• J. Eric Evans – President (Data inconclusive based on available public sources regarding concurrent title usage across reporting periods)

The company is governed by a board of directors that includes representatives affiliated with H.I.G. Capital as well as independent directors with healthcare, financial, and operational expertise.